During the past decade, Daegu Fatima Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Daegu Fatima Hospital" #1 sponsor was "Asan Medical Center" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Kyungpook National University Hospital" with 3 trials sponsored, "Keimyung University Dongsan Medical Center" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Daegu Fatima Hospital" #1 collaborator was "Korean Cancer Study Group" with 4 trials as a collaborator, "National Clinical Research Coordination Center, Seoul, Korea" with 2 trials as a collaborator, "Asan Medical Center" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Biotronik SE & Co. KG" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Daegu Fatima Hospital" are "Cerebral Palsy" (4 trials), "Muscle Spasticity" (4 trials), "Pediatrics" (4 trials), "Stroke" (3 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Daegu Fatima Hospital" in a lesser frequency.

Most popular intervention types in "Daegu Fatima Hospital" are "Drug" (12 trials), "Biological" (4 trials), "Device" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botulinum Toxin Type A" (2 trials), "Normal Saline (Placebo)" (2 trials), "botulinum toxin Type A" (2 trials), "Aspirin" (1 trials) and "Cilostazol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Daegu Fatima Hospital" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Daegu Fatima Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Daegu Fatima Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Daegu Fatima Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".